• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物不相容性与复杂制剂:让我们保持警惕!

Drug Incompatibilities and Complex Assemblies: Let Us Remain Vigilant!

作者信息

Salomez-Ihl Cordélia, Martin Mena Anthony, Molina Marie-Carmen, Chapuis Romane, Durand Marjorie, Chanoine Sébastien, Leenhardt Julien, Py Philippe, Brunet Marie-Dominique, Wong Yung-Sing, Chevallier Marie, Décaudin Bertrand, Odou Pascal, Bedouch Pierrick, Mazet Roseline

机构信息

Pharmacy Department, Grenoble University Hospital, F-38000 Grenoble, France.

THEMAS, TIMC-IMAG UMR CNRS 5525, Faculty of Pharmacy and Medicine, University Grenoble Alpes, F-38000 Grenoble, France.

出版信息

Pharmaceuticals (Basel). 2025 Apr 25;18(5):626. doi: 10.3390/ph18050626.

DOI:10.3390/ph18050626
PMID:40430447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12114821/
Abstract

: Multi-lumen devices that limit physicochemical incompatibilities (PCIs) are frequently used in neonatal intensive care units where premature infants receive numerous infusions. The aim of the study was to investigate a PCI that occurred despite the use of a device of this type (EDELVAISS Multiline NEO, Doran International, Toussieu, France). : A 7-week-old preterm infant received ganciclovir at therapeutic dosage for cytomegalovirus (CMV) infection. After the fifth administration of ganciclovir, a PCI occurred, leading to a white precipitate. The peripheral inserted central catheter (PICC) (PREMICATH2Fr, Vygon, Ecouen, France) had to be replaced. Laboratory reproduction of the administrations during 72 h, nuclear magnetic resonance (NMR) analysis and particle counting were carried out to analyse the occurrence of events leading to PCIs. The precipitate was linked to a PCI of parenteral nutrition associated with a dilution error of ganciclovir (omission of a 10-fold dilution step, resulting in ganciclovir being administered at 30 mg/L instead of 3 mg/L). Due to the presence of lipids in the parenteral nutrition, visual detection of the white precipitate was difficult. : Multi-lumen infusion devices limit but do not prevent the occurrence of PCIs, particularly in the event of a preparation error. Despite the use of this type of device, great vigilance is still required, particularly with regard to prescription analysis and reconstitution procedures.

摘要

在早产儿接受大量输液的新生儿重症监护病房中,常使用能减少物理化学不相容性(PCIs)的多腔设备。本研究的目的是调查尽管使用了此类设备(法国图西厄多兰国际公司的EDELVAISS Multiline NEO)仍发生的一种PCIs情况。

一名7周大的早产儿因巨细胞病毒(CMV)感染接受治疗剂量的更昔洛韦。在第五次输注更昔洛韦后,发生了一次PCIs,导致出现白色沉淀。不得不更换外周静脉穿刺中心静脉导管(PICC)(法国埃库昂维贡公司的PREMICATH2Fr)。在72小时内对输注过程进行实验室重现、核磁共振(NMR)分析和颗粒计数,以分析导致PCIs事件的发生情况。沉淀与肠外营养的PCIs有关,原因是更昔洛韦稀释错误(遗漏了10倍稀释步骤,导致更昔洛韦以30mg/L而非3mg/L的浓度给药)。由于肠外营养中存在脂质,很难目视检测到白色沉淀。

多腔输液设备能减少但不能防止PCIs的发生,尤其是在出现配制错误的情况下。尽管使用了此类设备,仍需高度警惕,特别是在处方分析和复溶程序方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20b8/12114821/c316aa4eca66/pharmaceuticals-18-00626-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20b8/12114821/c316aa4eca66/pharmaceuticals-18-00626-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20b8/12114821/c316aa4eca66/pharmaceuticals-18-00626-g001.jpg

相似文献

1
Drug Incompatibilities and Complex Assemblies: Let Us Remain Vigilant!药物不相容性与复杂制剂:让我们保持警惕!
Pharmaceuticals (Basel). 2025 Apr 25;18(5):626. doi: 10.3390/ph18050626.
2
Compatibility of medications during multi-infusion therapy: A controlled in vitro study on a multilumen infusion device.多输液治疗期间药物的相容性:多腔输液器的对照体外研究。
Anaesth Crit Care Pain Med. 2015 Apr;34(2):83-8. doi: 10.1016/j.accpm.2014.06.003. Epub 2015 Apr 7.
3
Effect of multi-lumen perfusion line on catheter-related bacteremia in premature infants: study protocol for a cluster-randomized crossover trial.多腔灌注管路对早产儿导管相关菌血症的影响:一项整群随机交叉试验的研究方案
Trials. 2019 Feb 11;20(1):115. doi: 10.1186/s13063-019-3218-6.
4
The impact of multilumen infusion devices on the occurrence of known physical drug incompatibility: a controlled in vitro study.多腔输液器对已知物理药物不相容性发生的影响:一项对照体外研究。
Anesth Analg. 2013 Jan;116(1):101-6. doi: 10.1213/ANE.0b013e31826f5e02. Epub 2012 Dec 7.
5
Prevention of drug delivery disturbances during continuous intravenous infusion: an in vitro study on a new multi-lumen infusion access device.连续静脉输注过程中药物输送干扰的预防:一种新型多腔输液通路装置的体外研究
Ann Fr Anesth Reanim. 2013 Sep;32(9):e107-12. doi: 10.1016/j.annfar.2013.06.017. Epub 2013 Aug 16.
6
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
7
Percutaneous central venous catheters versus peripheral cannulae for delivery of parenteral nutrition in neonates.经皮中心静脉导管与外周静脉套管用于新生儿肠外营养输注的比较
Cochrane Database Syst Rev. 2007 Jul 18(3):CD004219. doi: 10.1002/14651858.CD004219.pub3.
8
Extravasation of total parenteral nutrition into the liver from an upper extremity peripherally inserted central venous catheter.全胃肠外营养经上肢外周静脉穿刺中心静脉导管外渗至肝脏。
J Neonatal Perinatal Med. 2018;11(1):101-104. doi: 10.3233/NPM-181726.
9
Effect of in-line filtration in newborns: study protocol of the Intravenous Neonatal Central Access Safety (INCAS) randomized controlled trial.在线过滤对新生儿的影响:静脉新生儿中央通路安全(INCAS)随机对照试验研究方案。
Trials. 2024 Jul 6;25(1):459. doi: 10.1186/s13063-024-08264-w.
10
[Infusion sets in neonatology: What practices in France?].[新生儿科的输液装置:法国的实践情况如何?]
Ann Pharm Fr. 2022 Jul;80(4):584-596. doi: 10.1016/j.pharma.2021.08.011. Epub 2021 Sep 4.

本文引用的文献

1
The potential for drug incompatibility and its drivers - A hospital wide retrospective descriptive study.药物不相容性的潜在风险及其驱动因素——一项全院范围的回顾性描述性研究。
Int J Med Inform. 2024 Nov;191:105584. doi: 10.1016/j.ijmedinf.2024.105584. Epub 2024 Jul 31.
2
Cost-effectiveness of a new multi-lumen infusion device to reduce central-venous-line-associated bloodstream infections in neonates.一种新的多腔输液器降低新生儿中心静脉相关血流感染的成本效益。
J Hosp Infect. 2024 Oct;152:114-121. doi: 10.1016/j.jhin.2024.06.019. Epub 2024 Jul 18.
3
Optimising an Infusion Protocol Containing Cefepime to Limit Particulate Load to Newborns in a Neonatal Intensive Care Unit.
优化含头孢吡肟的输注方案以限制新生儿重症监护病房中新生儿的微粒负荷
Pharmaceutics. 2021 Mar 8;13(3):351. doi: 10.3390/pharmaceutics13030351.
4
Strategies to prevent drug incompatibility during simultaneous multi-drug infusion in intensive care units: a literature review.策略以防止药物不相容性在重症监护病房同时多药物输注期间:文献回顾。
Eur J Clin Pharmacol. 2021 Sep;77(9):1309-1321. doi: 10.1007/s00228-021-03112-1. Epub 2021 Mar 25.
5
Retrospective multicentre matched cohort study comparing safety and efficacy outcomes of intermittent-infusion versus continuous-infusion vancomycin.比较间歇性输注与持续性输注万古霉素的安全性和疗效结果的回顾性多中心匹配队列研究。
J Antimicrob Chemother. 2020 Apr 1;75(4):1038-1046. doi: 10.1093/jac/dkz531.
6
Evaluation of Incompatible Coadministration of Continuous Intravenous Infusions in a Pediatric/Neonatal Intensive Care Unit.儿科/新生儿重症监护病房中连续静脉输注不相容联合用药的评估
J Pediatr Pharmacol Ther. 2019 Nov-Dec;24(6):479-488. doi: 10.5863/1551-6776-24.6.479.
7
Continuous Versus Intermittent Vancomycin Infusions in Infants: A Randomized Controlled Trial.连续与间断万古霉素输注在婴儿中的应用:一项随机对照试验。
Pediatrics. 2019 Feb;143(2). doi: 10.1542/peds.2018-2179.
8
Drug incompatibilities in intravenous therapy: evaluation and proposition of preventive tools in intensive care and hematology units.静脉治疗中的药物不相容性:重症监护和血液科预防措施的评估与建议
Eur J Clin Pharmacol. 2019 Feb;75(2):179-187. doi: 10.1007/s00228-018-2602-6. Epub 2018 Dec 12.
9
Clinical implications of intravenous drug incompatibilities in critically ill patients.危重症患者静脉药物不相容的临床意义。
Anaesth Crit Care Pain Med. 2019 Apr;38(2):173-180. doi: 10.1016/j.accpm.2018.04.003. Epub 2018 Apr 19.
10
Risk Factors and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infection in Solid Organ Transplant Recipients.实体器官移植受者中更昔洛韦耐药巨细胞病毒感染的危险因素和结局。
Clin Infect Dis. 2017 Jul 1;65(1):57-63. doi: 10.1093/cid/cix259.